Skip Navigation



Human Molecular Genetics Advance Access published online on September 20, 2005

Human Molecular Genetics, doi:10.1093/hmg/ddi351
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
14/21/3203    most recent
ddi351v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sardiello, M.
Right arrow Articles by Ballabio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sardiello, M.
Right arrow Articles by Ballabio, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved
Received June 30, 2005
Revised September 14, 2005
Accepted September 14, 2005

Article

Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship

Marco Sardiello 1, Ida Annunziata 1, Guglielmo Roma 1, and Andrea Ballabio 2*

1 Telethon Institute of Genetics and Medicine, Via Pietro Castellino 111, 80131 Naples, Italy
2 Telethon Institute of Genetics and Medicine, Via Pietro Castellino 111, 80131 Naples, Italy; Medical Genetics, Department of Pediatrics, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy

* To whom correspondence should be addressed.
Andrea Ballabio, E-mail: ballabio{at}tigem.it


   Abstract

Sulfatases catalyze the hydrolysis of sulfate ester bonds from a wide variety of substrates. Several human inherited diseases are caused by the deficiency of individual sulfatases, while in patients with multiple sulfatase deficiency mutations in the Sulfatase Modifying Factor 1 (SUMF1) gene cause a defect in the post-translational modification of a cysteine residue into C{alpha}-formylglycine (FGly) at the active site of all sulfatases. This unique modification mechanism, which is required for catalytic activity, has been highly conserved during evolution. Here we used a genomic approach to investigate the relationship between sulfatases and their modifying factors in humans and several model systems. Firstly, we determined the complete catalogue of human sulfatases, which is comprised of 17 members (vs. 14 in rodents), including four novel ones (ARSH, ARSI, ARSJ, and ARSK). Secondly, we showed that the active site, which is the target of the post-translational modification, is the most evolutionarily constrained region of sulfatases and shows intraspecies sequence convergence. Exhaustive sequence analyses of available proteomes indicate that sulfatases are the only likely targets of their modifying factors. Thirdly, we showed that sulfatases and ectonucleotide pyrophosphatases share significant homology at their active sites, suggesting a common evolutionary origin as well as similar catalytic mechanisms. Most importantly, gene association studies performed on prokaryotes suggested the presence of at least two additional mechanisms of cysteine-to-FGly conversion that do not require SUMF1. These results may have important implications in the study of diseases caused by sulfatase deficiencies and in the development of therapeutic strategies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
C. Spatuzza, M. Schiavone, E. Di Salle, E. Janda, M. Sardiello, G. Fiume, O. Fierro, M. Simonetta, N. Argiriou, R. Faraonio, et al.
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk
Nucleic Acids Res., July 2, 2008; (2008) gkn413v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-A. Frese, S. Schulz, and T. Dierks
Arylsulfatase G, a Novel Lysosomal Sulfatase
J. Biol. Chem., April 25, 2008; 283(17): 11388 - 11395.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Tomatsu, A. M. Montano, A. Ohashi, M. A. Gutierrez, H. Oikawa, T. Oguma, V. C. Dung, T. Nishioka, T. Orii, and W. S. Sly
Enzyme replacement therapy in a murine model of Morquio A syndrome
Hum. Mol. Genet., March 15, 2008; 17(6): 815 - 824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mariappan, K. Radhakrishnan, T. Dierks, B. Schmidt, and K. von Figura
ERp44 Mediates a Thiol-independent Retention of Formylglycine-generating Enzyme in the Endoplasmic Reticulum
J. Biol. Chem., March 7, 2008; 283(10): 6375 - 6383.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Settembre, I. Annunziata, C. Spampanato, D. Zarcone, G. Cobellis, E. Nusco, E. Zito, C. Tacchetti, M. P. Cosma, and A. Ballabio
Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency
PNAS, March 13, 2007; 104(11): 4506 - 4511.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Berteau, A. Guillot, A. Benjdia, and S. Rabot
A New Type of Bacterial Sulfatase Reveals a Novel Maturation Pathway in Prokaryotes
J. Biol. Chem., August 11, 2006; 281(32): 22464 - 22470.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.